Erythrocytoses in patients with dilated and ischemic cardiomyopathy.

The aim of research was to evaluate the impact of erythrocytoses on processes of cardiovascular system's remodelling in patients with dilated and ishaemic cardiomyopathies. 35 (42,2%) patients with dilated cardiomyopathy (DCMP) with erythrocytoses, 19 (23,5%) without erythrocytosis, 34 (28,4%)...

Full description

Saved in:
Bibliographic Details
Published inKlinicheskaia laboratornaia diagnostika Vol. 65; no. 4; p. 222
Main Authors Chepurnaya, A N, Safuanova, G S, Nikulicheva, V I, Lekhmus, T Y, Rakhmatullina, A R
Format Journal Article
LanguageRussian
Published Russia (Federation) 2020
Subjects
hypoxia
ischemic cardiomyopathy
erythrocytoses
dilated cardiomyopathy
Online AccessGet more information

Cover

More Information
Summary:The aim of research was to evaluate the impact of erythrocytoses on processes of cardiovascular system's remodelling in patients with dilated and ishaemic cardiomyopathies. 35 (42,2%) patients with dilated cardiomyopathy (DCMP) with erythrocytoses, 19 (23,5%) without erythrocytosis, 34 (28,4%) patients with ishaemic cardiomyopathy (ICMP) with erythrocytosis and 50 (60,1%) without erythrocytosis were included in the study. It has been established that erythrocytoses don't wield major influence on the heart's haemodynamics, they appear as a consequence of main diseases and not as their reason, which confirms the domination of congestive heart failure's signs of III-IV stages. In patients with DCMP and ICMP signs of tissue hypoxia were established as well as oxygen reduction in arterial blood to 60,70 ± 1,24 mm Hg in cases of DCMP and 59,60 ± 1,24 mm Hg in cases of ICMP (in verification 75,44 ± 0,93) - p < 0,001. Arguably, erythrocytoses in cases of DCMP and ICMP are a consequence of congestive heart failure, leading to hypoxic erythrocytosis.
ISSN:0869-2084